Pine Valley Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Buy
+48,469
New +$2.08M 0.09% 201
2024
Q4
Sell
-1,960
Closed -$233K 541
2024
Q3
$233K Sell
1,960
-15
-0.8% -$2K 0.01% 455
2024
Q2
$282K Buy
1,975
+244
+14% +$32.3K 0.02% 398
2024
Q1
$224K Buy
+1,731
New +$206K 0.02% 454

Other funds holding NVO

Pine Valley Investments's NVO Position: Q2 2026 in Review

Pine Valley Investments opened a new position in Novo Nordisk (NVO) in Q2 2026: 48,469 shares worth $2.32M. The stake represents 0.09% of the portfolio and ranks #201 among its holdings. This is a return to the name: Pine Valley Investments previously reported a position in NVO as recently as Q3 2024.

Pine Valley Investments first reported a position in NVO in Q1 2024 and has held it in 4 quarters since. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Pine Valley Investments held 48,469 shares of Novo Nordisk worth $2.32M as of Q2 2026.
  • Novo Nordisk was a new Pine Valley Investments position in Q2 2026.
  • Novo Nordisk made up 0.09% of Pine Valley Investments's portfolio in Q2 2026, its #201 holding.
  • Pine Valley Investments first reported a position in Novo Nordisk in Q1 2024 and has held it in 4 quarters since.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.